Subgroup analysis of clinical trials.

By M. Gheorghiade, L. Schultz, B. Tilley, W. Kao, S. Goldstein. 1991

Citations in the corpus

• From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer (2012, unknown): “specified [6,7].”
• An introduction to multiplicity issues in clinical trials: the what, why, when and how. (2016, unknown): “Subgroup analyses satisfying the three aforementioned conditions are considered as having a confirmatory nature, thereby requiring multiplicity adjustments.(5,24,43,44) Whereas many trials pre-specify subgroup analyses which are considered supportive to examine treatment consistency, others conduct ”